3/4
08:06 am
qdel
QuidelOrtho Co. (NASDAQ: QDEL) had its "sell" rating re-affirmed by analysts at UBS Group AG. They now have a $42.00 price target on the stock, down previously from $70.00.
Low
Report
QuidelOrtho Co. (NASDAQ: QDEL) had its "sell" rating re-affirmed by analysts at UBS Group AG. They now have a $42.00 price target on the stock, down previously from $70.00.
3/4
05:59 am
qdel
Rating for QDEL
Low
Report
Rating for QDEL
2/14
12:16 pm
qdel
QuidelOrtho Co. (NASDAQ: QDEL) had its "hold" rating re-affirmed by analysts at Craig Hallum.
Medium
Report
QuidelOrtho Co. (NASDAQ: QDEL) had its "hold" rating re-affirmed by analysts at Craig Hallum.
2/14
12:16 pm
qdel
QuidelOrtho Co. (NASDAQ: QDEL) had its "hold" rating re-affirmed by analysts at Craig Hallum.
Medium
Report
QuidelOrtho Co. (NASDAQ: QDEL) had its "hold" rating re-affirmed by analysts at Craig Hallum.
2/14
12:11 pm
qdel
Rating for QDEL
Medium
Report
Rating for QDEL
2/14
12:11 pm
qdel
Rating for QDEL
Medium
Report
Rating for QDEL
2/14
10:39 am
qdel
Rating for QDEL
Low
Report
Rating for QDEL
2/14
10:39 am
qdel
Rating for QDEL
Low
Report
Rating for QDEL
2/14
08:40 am
qdel
QuidelOrtho Co. (NASDAQ: QDEL) had its "market perform" rating re-affirmed by analysts at William Blair.
Medium
Report
QuidelOrtho Co. (NASDAQ: QDEL) had its "market perform" rating re-affirmed by analysts at William Blair.
2/14
08:40 am
qdel
QuidelOrtho Co. (NASDAQ: QDEL) had its "market perform" rating re-affirmed by analysts at William Blair.
Medium
Report
QuidelOrtho Co. (NASDAQ: QDEL) had its "market perform" rating re-affirmed by analysts at William Blair.
2/14
08:40 am
qdel
QuidelOrtho Co. (NASDAQ: QDEL) had its "outperform" rating re-affirmed by analysts at Raymond James. They now have a $76.00 price target on the stock, down previously from $100.00.
Medium
Report
QuidelOrtho Co. (NASDAQ: QDEL) had its "outperform" rating re-affirmed by analysts at Raymond James. They now have a $76.00 price target on the stock, down previously from $100.00.
2/14
08:40 am
qdel
QuidelOrtho Co. (NASDAQ: QDEL) had its "outperform" rating re-affirmed by analysts at Raymond James. They now have a $76.00 price target on the stock, down previously from $100.00.
Medium
Report
QuidelOrtho Co. (NASDAQ: QDEL) had its "outperform" rating re-affirmed by analysts at Raymond James. They now have a $76.00 price target on the stock, down previously from $100.00.
2/14
08:28 am
qdel
Rating for QDEL
Medium
Report
Rating for QDEL
2/14
08:28 am
qdel
Rating for QDEL
Medium
Report
Rating for QDEL
2/14
08:25 am
qdel
Rating for QDEL
Medium
Report
Rating for QDEL
2/14
08:25 am
qdel
Rating for QDEL
Medium
Report
Rating for QDEL
2/14
07:27 am
qdel
Rating for QDEL
High
Report
Rating for QDEL
2/14
07:10 am
qdel
QuidelOrtho Co. (NASDAQ: QDEL) was downgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "underweight" rating. They now have a $37.00 price target on the stock, down previously from $66.00.
Medium
Report
QuidelOrtho Co. (NASDAQ: QDEL) was downgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "underweight" rating. They now have a $37.00 price target on the stock, down previously from $66.00.